Terms: = Lymphoma AND TTL, 2410003M22Rik, 150465, ENSG00000114999, MGC46235, Q8NG68 AND Treatment
3 results:
1. Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas.
Barreca M; Spanò V; Rocca R; Bivacqua R; Abel AC; Maruca A; Montalbano A; Raimondi MV; Tarantelli C; Gaudio E; Cascione L; Rinaldi A; Bai R; Steinmetz MO; Prota AE; Alcaro S; Hamel E; Bertoni F; Barraja P
Eur J Med Chem; 2022 Dec; 243():114744. PubMed ID: 36242921
[TBL] [Abstract] [Full Text] [Related]
2. Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia.
Alruwetei AM; Bendak K; Yadav BD; Carol H; Evans K; Mayoh C; Sutton R; Marshall GM; Lock RB
Br J Cancer; 2020 Sep; 123(5):742-751. PubMed ID: 32536690
[TBL] [Abstract] [Full Text] [Related]
3. Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways.
Meyer LH; Eckhoff SM; Queudeville M; Kraus JM; Giordan M; Stursberg J; Zangrando A; Vendramini E; Möricke A; Zimmermann M; Schrauder A; Lahr G; Holzmann K; Schrappe M; Basso G; Stahnke K; Kestler HA; Te Kronnie G; Debatin KM
Cancer Cell; 2011 Feb; 19(2):206-17. PubMed ID: 21295523
[TBL] [Abstract] [Full Text] [Related]
